JP2006514645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514645A5 JP2006514645A5 JP2004560488A JP2004560488A JP2006514645A5 JP 2006514645 A5 JP2006514645 A5 JP 2006514645A5 JP 2004560488 A JP2004560488 A JP 2004560488A JP 2004560488 A JP2004560488 A JP 2004560488A JP 2006514645 A5 JP2006514645 A5 JP 2006514645A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy tamoxifen
- subject
- transdermally
- performing mammography
- transdermally administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 6
- DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 claims 4
- 210000000481 breast Anatomy 0.000 claims 2
- 238000009607 mammography Methods 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43395802P | 2002-12-18 | 2002-12-18 | |
| PCT/EP2003/015030 WO2004054558A2 (en) | 2002-12-18 | 2003-12-15 | Reduction of breast density with 4-hydroxy tamoxifen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010279107A Division JP2011052020A (ja) | 2002-12-18 | 2010-12-15 | 4−ヒドロキシタモキシフェンによる乳房密度低下 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006514645A JP2006514645A (ja) | 2006-05-11 |
| JP2006514645A5 true JP2006514645A5 (cg-RX-API-DMAC7.html) | 2007-02-08 |
| JP4684655B2 JP4684655B2 (ja) | 2011-05-18 |
Family
ID=32595254
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004560488A Expired - Lifetime JP4684655B2 (ja) | 2002-12-18 | 2003-12-15 | 4−ヒドロキシタモキシフェンによる乳房密度低下 |
| JP2010279107A Pending JP2011052020A (ja) | 2002-12-18 | 2010-12-15 | 4−ヒドロキシタモキシフェンによる乳房密度低下 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010279107A Pending JP2011052020A (ja) | 2002-12-18 | 2010-12-15 | 4−ヒドロキシタモキシフェンによる乳房密度低下 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7485623B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2050443B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4684655B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003296757A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60327363D1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004054558A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002366800B2 (en) * | 2001-12-20 | 2006-08-03 | Femmepharma Holding Company, Inc. | Vaginal delivery of drugs |
| EP1572178B1 (en) * | 2002-12-18 | 2006-05-03 | Laboratoires Besins International | Treatment of mastalgia with 4-hydroxy tamoxifen |
| US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| US7812010B2 (en) * | 2003-01-02 | 2010-10-12 | Femmepharma, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| CA2519980C (en) * | 2003-04-01 | 2012-04-10 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| DE602004013439T2 (de) | 2003-06-09 | 2009-06-04 | Ascend Therapeutics, Inc. | Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen |
| US7968532B2 (en) * | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| AU2005227072B2 (en) * | 2004-03-22 | 2010-08-19 | Besins Healthcare Luxembourg Sarl | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| CA2582174C (en) * | 2004-10-14 | 2013-01-29 | Laboratoires Besins International | 4-hydroxy tamoxifen gel formulations |
| GB0602739D0 (en) * | 2006-02-10 | 2006-03-22 | Ccbr As | Breast tissue density measure |
| EP2104489A2 (en) * | 2006-12-26 | 2009-09-30 | FemmePharma Holding Company, Inc. | Topical administration of danazol |
| US20100303786A1 (en) * | 2007-11-22 | 2010-12-02 | Novo Nordisk Health Care Ag | Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing Compounds |
| US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
| CN110044998B (zh) * | 2014-05-12 | 2021-12-14 | 奎斯特诊断投资公司 | 通过质谱法定量他莫昔芬及其代谢物 |
| EP3484463B1 (en) | 2016-08-19 | 2020-02-12 | The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology Transfer | Selective estrogen-receptor modulators (serms) confer protection against photoreceptor degeneration |
| EP3681491A4 (en) | 2017-09-11 | 2021-06-30 | Atossa Therapeutics, Inc. | PROCESS FOR MANUFACTURING AND USE OF ENDOXIFES |
| WO2021003433A1 (en) | 2019-07-03 | 2021-01-07 | Atossa Therapeutics, Inc. | Sustained release compositions of endoxifen |
| WO2023026139A1 (en) * | 2021-08-23 | 2023-03-02 | Singh Divya Dhananjay | Pharmaceutical composition comprising 4- hydroxytamoxifen for the treatment of mastalgia |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| ATE80152T1 (de) * | 1987-04-21 | 1992-09-15 | Heumann Pharma Gmbh & Co | Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en. |
| US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| US5002938A (en) * | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| DE3836862A1 (de) | 1988-10-27 | 1990-05-03 | Schering Ag | Mittel zur transdermalen applikation von steroidhormonen |
| TW218849B (cg-RX-API-DMAC7.html) | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| JPH0679002A (ja) * | 1993-12-14 | 1994-03-22 | Hisamitsu Pharmaceut Co Inc | 経皮投与用パッチシステム |
| US5613958A (en) | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| DE4407742C1 (de) * | 1994-03-08 | 1995-06-22 | Hexal Pharma Gmbh | Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat |
| US5720963A (en) * | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| DE4434165A1 (de) * | 1994-09-24 | 1996-03-28 | Cassella Ag | Haarfärbemittel |
| US6083996A (en) * | 1997-11-05 | 2000-07-04 | Nexmed Holdings, Inc. | Topical compositions for NSAI drug delivery |
| US6013270A (en) * | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| EP1317921B1 (fr) * | 2001-12-07 | 2009-08-19 | Besins International Belgique | Composition pharmaceutique sous forme de gel ou de solution à base de dihydrotestostérone, son procédé de préparation et ses utilisations |
| EP1572178B1 (en) * | 2002-12-18 | 2006-05-03 | Laboratoires Besins International | Treatment of mastalgia with 4-hydroxy tamoxifen |
| CA2519980C (en) * | 2003-04-01 | 2012-04-10 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| DE602004013439T2 (de) | 2003-06-09 | 2009-06-04 | Ascend Therapeutics, Inc. | Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen |
| US7968532B2 (en) * | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
-
2003
- 2003-12-15 EP EP09000839.2A patent/EP2050443B1/en not_active Expired - Lifetime
- 2003-12-15 WO PCT/EP2003/015030 patent/WO2004054558A2/en not_active Ceased
- 2003-12-15 JP JP2004560488A patent/JP4684655B2/ja not_active Expired - Lifetime
- 2003-12-15 DE DE60327363T patent/DE60327363D1/de not_active Expired - Lifetime
- 2003-12-15 EP EP08103001.7A patent/EP1952809B1/en not_active Expired - Lifetime
- 2003-12-15 US US10/734,644 patent/US7485623B2/en not_active Expired - Lifetime
- 2003-12-15 AU AU2003296757A patent/AU2003296757A1/en not_active Abandoned
- 2003-12-15 EP EP03813147A patent/EP1572171B1/en not_active Expired - Lifetime
-
2010
- 2010-12-15 JP JP2010279107A patent/JP2011052020A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514967A5 (cg-RX-API-DMAC7.html) | ||
| WO2004054558A3 (en) | Reduction of breast density with 4-hydroxy tamoxifen | |
| MX2007000420A (es) | Suplemento de electrolito y metodo de uso. | |
| CN204218038U (zh) | 一种多功能保健鞋垫 | |
| JP2006514949A5 (cg-RX-API-DMAC7.html) | ||
| CN114401749A (zh) | 一种放射性核素标记物及其应用 | |
| CN107467726B (zh) | 一种多功能复合胸垫及其制备方法和胸罩 | |
| CN211272183U (zh) | 一种骨科脊柱用术后康复装置 | |
| CN201631226U (zh) | 一次性超声波探头套 | |
| CN1723936A (zh) | 一种抗抑郁症的中药及其制备方法 | |
| CN203506952U (zh) | 外科手指骨折固定器 | |
| CN220778856U (zh) | 一种旋转式超声聚焦装置 | |
| CN201870400U (zh) | 一种穿鞋袜辅助装置 | |
| CN201167436Y (zh) | 显示器外壳 | |
| CN205144944U (zh) | 一种手术后防压支撑架 | |
| CN209966675U (zh) | 一种便于使用的精神护理用嘴部支撑器 | |
| CN202236048U (zh) | 脑外科多功能枕 | |
| CN208541507U (zh) | 冠心病pci术后上肢抬高垫 | |
| CN208002813U (zh) | 一种内科大夫用的听诊器 | |
| CN201244148Y (zh) | 俯卧位头面部支架 | |
| CN208625958U (zh) | 一种骨科临床骨折用续骨装置 | |
| CN209059972U (zh) | 一种科研及临床用针灸套管 | |
| CN205432147U (zh) | 一种中草药保健的硅胶垫片 | |
| YOSHIDA et al. | A case of a cemento-ossifying fibroma associated with multiple impacted teeth arising in the right maxillary bone | |
| CN203576540U (zh) | 心内科听诊器 |